Page last updated: 2024-12-07

4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine: structure given in first source; 5-bromotubercidin in which the ribose is replaced by 2-hydroxyethoxymethyl [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122682
CHEMBL ID63480
SCHEMBL ID8442394
MeSH IDM0170775

Synonyms (17)

Synonym
2-[(4-amino-5-bromo-pyrrolo[2,3-d]pyrimidin-7-yl)methoxy]ethanol
5-bromo acyclic tubercidin
4-amino-5-bromo-7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidine
115093-88-4
abhempp
CHEMBL63480
2-[(4-amino-5-bromopyrrolo[2,3-d]pyrimidin-7-yl)methoxy]ethanol
ethanol, 2-((4-amino-5-bromo-7h-pyrrolo(2,3-d)pyrimidin-7-yl)methoxy)-
4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine
4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo[2,3-d]-pyrimidine
4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo[2,3-d] pyrimidine
4amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo[2,3-d]-pyrimidine
RMOPBCMNPLURLP-UHFFFAOYSA-N
SCHEMBL8442394
DTXSID90150962
4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo[2,3-d]pyrimidine
2-((4-amino-5-bromo-7h-pyrrolo[2,3-d]pyrimidin-7-yl)methoxy)ethanol

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" These mt-QSARs offer also a good opportunity to construct drug-drug Complex Networks (CNs) that can be used to explore large and complex drug-viral species databases."( Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID90617Inhibitory concentration against human cytomegalovirus (HCMV) in plaque reduction assay1988Journal of medicinal chemistry, Nov, Volume: 31, Issue:11
Synthesis and antiviral activity of certain 4- and 4,5-disubstituted 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidines.
AID392502Antiviral activity against Herpes simplex virus2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
AID96400Cytotoxicity against human neoplastic cell line(KB cells)1988Journal of medicinal chemistry, Nov, Volume: 31, Issue:11
Synthesis and antiviral activity of certain 4- and 4,5-disubstituted 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidines.
AID42131Cytotoxicity against uninfected monkey kidney cells (BSC-1)1988Journal of medicinal chemistry, Nov, Volume: 31, Issue:11
Synthesis and antiviral activity of certain 4- and 4,5-disubstituted 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidines.
AID91294Cytotoxicity against uninfected human foreskin fibroblast(HFF cells)1988Journal of medicinal chemistry, Nov, Volume: 31, Issue:11
Synthesis and antiviral activity of certain 4- and 4,5-disubstituted 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidines.
AID96214Cytotoxicity against human neoplastic cell line(KB cells)1988Journal of medicinal chemistry, Nov, Volume: 31, Issue:11
Synthesis and antiviral activity of certain 4- and 4,5-disubstituted 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidines.
AID87344Inhibitory concentration against HCMV in plaque reduction assay1988Journal of medicinal chemistry, Nov, Volume: 31, Issue:11
Synthesis and antiviral activity of certain 4- and 4,5-disubstituted 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.38 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]